Shire / Viropharma
The CMA investigated the completed acquisition by Shire Plc of Viropharma Incorporated.
|8 April 2014||Decision published|
|10 February 2014||Decision announced|
|9 December to 20 December 2013||Invitation to comment|
|6 December 2013||Launch of merger inquiry|
(*)This date is the current administrative deadline by when the decision will be announced. If any change occurs, the information is refreshed as soon as practicable. However, the CMA cannot guarantee that the decision will be announced on or before this current deadline, as the deadline of a given case may change during the merger assessment process due to different reasons.
OFT clearance decision
The decision was announced on 10 February 2014. The full text of the decision is available below:
- Full text decision (8.4.14)
Invitation to comment: Now closed
The OFT is considering whether this acquisition has resulted in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.
Launch of CMA merger inquiry
6 December 2013: The OFT launched its merger inquiry following receipt of a satisfactory submission.
Please send written representations about any competition or public interest to:
Clementine de Brosses
Competition and Markets Authority
37 Southampton Row